Atlas Trials

A Single Ascending Dose Study Investigating the Safety, Pharmacokinetics and Pharmacodynamics of RO6836191 in Healthy Male Volunteers.

Clinical trial NCT01995383 · COMPLETED

Trial details

NCT number
NCT01995383
Sponsor
Hoffmann-La Roche
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Atherosclerosis
Start date
2013-11-01
Primary completion
2014-06-01
Enrollment
88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.